drugset / Trial / NCT01262300
Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents
Phase 1
Completed
33 enrolled
University of Colorado, Denver
Merck Sharp & Dohme LLC · collabNational Institute on Aging (NIA) · collab
NaSingle-groupOpen-labelPrevention
Summary
This is an ancillary study to a randomized controlled trial of high dose vitamin D in older long-term care residents (NCT01102374). In this study, a subset of trial subjects will receive the zoster vaccine and the investigators will determine the immunological response to the vaccine in this older, frail population, as well as the association between vitamin D and immunological outcomes.
Timeline
- Start
- 2010-11
- Primary completion
- 2014-01-23
- Completion
- 2014-01-23
Publications
- Background A randomized controlled trial of high dose vitamin D in older long-term care residents (NCT01102374)
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Varivax | Vaccine | 0.65 ml | Subcutaneous |